View all reports
Protagonist Therapeutics, Inc. (PTGX) stock forecast and price target
Find the latest Protagonist Therapeutics, Inc. ptgx analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.
Date Range
investment rating
report type
sector
industry
provider
PTGXProtagonist Therapeutics, Inc.42.89 +0.60 (+1.42%)
At close: 08:00PM
Recommendation Rating
1.7
Analyst Price Targets (5)
Current?42.89
Average?46.80
Low?40.00
High?52.00
Related Research Reports1-7 of 7 results
| Report Name | Symbols | Sector | Provider | Date | |
|---|---|---|---|---|---|
| PTGX | Healthcare | Argus | Aug 28, 2024 | Upgrade to begin downloading full reports | |
| PTGX | Healthcare | Argus | Aug 21, 2024 | Upgrade to begin downloading full reports | |
| PTGX | Healthcare | Argus | Aug 14, 2024 | Upgrade to begin downloading full reports | |
| PTGX | Healthcare | Argus | Aug 07, 2024 | Upgrade to begin downloading full reports | |
| PTGX | Healthcare | Argus | Jul 31, 2024 | Upgrade to begin downloading full reports | |
| PTGX | Healthcare | Argus | Jul 24, 2024 | Upgrade to begin downloading full reports | |
| PTGX | Healthcare | Argus | Jul 17, 2024 | Upgrade to begin downloading full reports |